Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Celgene Corp /de/

Affiliations

  • Large Shareholder at Agios Pharmaceuticals Inc. (AGIO), 2019-11-14
  • at Acceleron Pharma Inc (XLRN), 2019-01-22
  • at Sutro Biopharma Inc (STRO), 2018-10-02
  • Large Shareholder at Juno Therapeutics Inc. (JUNO), 2018-03-06
  • Large Shareholder at Crispr Therapeutics Ag (CRSP), 2017-12-07
  • Large Shareholder at Alliqua Biomedical Inc. (ALQA), 2017-04-13
  • Large Shareholder at Jounce Therapeutics Inc. (JNCE), 2017-02-01
  • Large Shareholder at Receptos Inc. (RCPT), 2015-08-27
  • Large Shareholder at Globeimmune Inc (GBIM), 2014-07-08
  • Large Shareholder at Epizyme Inc. (EPZM), 2014-02-11
  • Large Shareholder at Abraxis Bioscience Inc. (ABII), 2010-10-18
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
AGIO $31.00 403,225 Large Shareholder 1,777,824 2019-11-12 Filing
XLRN $43.00 706,206 6,824,685 2019-01-18 Filing
AGIO $67.00 851,154 Large Shareholder 1,374,599 2018-01-23 Filing
AGIO $67.00 851,154 Large Shareholder 1,374,599 2018-01-23 Filing
XLRN $37.00 745,592 Large Shareholder 6,118,479 2017-09-25 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
CRSP $19.47 30,485 Large Shareholder 3,722,534 2017-12-04 Filing
CRSP $19.10 87,991 Large Shareholder 3,753,019 2017-12-01 Filing
CRSP $19.04 12,666 Large Shareholder 3,841,010 2017-11-30 Filing
CRSP $19.25 4,263 Large Shareholder 3,853,676 2017-11-29 Filing
CRSP $19.22 5,080 Large Shareholder 3,857,939 2017-11-28 Filing